Matches in SemOpenAlex for { <https://semopenalex.org/work/W4288049407> ?p ?o ?g. }
- W4288049407 endingPage "e368" @default.
- W4288049407 startingPage "e360" @default.
- W4288049407 abstract "BackgroundThe TRACT trial established the timing of transfusion in children with uncomplicated anaemia (haemoglobin 4–6 g/dL) and the optimal volume (20 vs 30 mL/kg whole blood or 10 vs 15 mL/kg red cell concentrates) for transfusion in children admitted to hospital with severe anaemia (haemoglobin <6 g/dL) on day 28 mortality (primary endpoint). Because data on the safety of blood components are scarce, we conducted a secondary analysis to examine the safety and efficacy of different pack types (whole blood vs red cell concentrates) on clinical outcomes.MethodsThis study is a secondary analysis of the TRACT trial data restricted to those who received an immediate transfusion (using whole blood or red cell concentrates). TRACT was an open-label, multicentre, factorial, randomised trial conducted in three hospitals in Uganda (Soroti, Mbale, and Mulago) and one hospital in Malawi (Blantyre). The trial enrolled children aged between 2 months and 12 years admitted to hospital with severe anaemia (haemoglobin <6 g/dL). The pack type used (supplied by blood banks) was based only on availability at the time. The outcomes were haemoglobin recovery at 8 h and 180 days, requirement for retransfusion, length of hospital stay, changes in heart and respiratory rates until day 180, and the main clinical endpoints (mortality until day 28 and day 180, and readmission until day 180), measured using multivariate regression models.FindingsBetween Sept 17, 2014, and May 15, 2017, 3199 children with severe anaemia were enrolled into the TRACT trial. 3188 children were considered in our secondary analysis. The median age was 37 months (IQR 18–64). Whole blood was the first pack provided for 1632 (41%) of 3992 transfusions. Haemoglobin recovery at 8 h was significantly lower in those who received packed cells or settled cells than those who received whole blood, with a mean of 1·4 g/dL (95% CI –1·6 to –1·1) in children who received 30 mL/kg and –1·3 g/dL (–1·5 to –1·0) in those who received 20 mL/kg packed cells versus whole blood, and –1·5 g/dL (–1·7 to –1·3) in those who received 30 mL/kg and –1·0 g/dL (–1·2 to –0·9) in those who received 20 mL/kg settled cells versus whole blood (overall p<0·0001). Compared to whole blood, children who received blood as packed or settled cells in their first transfusion had higher odds of receiving a second transfusion (odds ratio 2·32 [95% CI 1·30 to 4·12] for packed cells and 2·97 [2·18 to 4·05] for settled cells; p<0·001) and longer hospital stays (hazard ratio 0·94 [95% CI 0·81 to 1·10] for packed cells and 0·86 [0·79 to 0·94] for settled cells; p=0·0024). There was no association between the type of blood supplied for the first transfusion and mortality at 28 days or 180 days, or readmission to hospital for any cause. 823 (26%) of 3188 children presented with severe tachycardia and 2077 (65%) with tachypnoea, but these complications resolved over time. No child developed features of confirmed cardiopulmonary overload.InterpretationOur study suggests that the use of packed or settled cells rather than whole blood leads to additional transfusions, increasing the use of a scarce resource in most of sub-Saharan Africa. These findings have substantial cost implications for blood transfusion and health services. Nevertheless, a clinical trial comparing whole blood transfusion with red cell concentrates might be needed to inform policy makers.FundingUK Medical Research Council (MRC) and the Department for International Development.TranslationFor the French translation of the abstract see Supplementary Materials section. The TRACT trial established the timing of transfusion in children with uncomplicated anaemia (haemoglobin 4–6 g/dL) and the optimal volume (20 vs 30 mL/kg whole blood or 10 vs 15 mL/kg red cell concentrates) for transfusion in children admitted to hospital with severe anaemia (haemoglobin <6 g/dL) on day 28 mortality (primary endpoint). Because data on the safety of blood components are scarce, we conducted a secondary analysis to examine the safety and efficacy of different pack types (whole blood vs red cell concentrates) on clinical outcomes. This study is a secondary analysis of the TRACT trial data restricted to those who received an immediate transfusion (using whole blood or red cell concentrates). TRACT was an open-label, multicentre, factorial, randomised trial conducted in three hospitals in Uganda (Soroti, Mbale, and Mulago) and one hospital in Malawi (Blantyre). The trial enrolled children aged between 2 months and 12 years admitted to hospital with severe anaemia (haemoglobin <6 g/dL). The pack type used (supplied by blood banks) was based only on availability at the time. The outcomes were haemoglobin recovery at 8 h and 180 days, requirement for retransfusion, length of hospital stay, changes in heart and respiratory rates until day 180, and the main clinical endpoints (mortality until day 28 and day 180, and readmission until day 180), measured using multivariate regression models. Between Sept 17, 2014, and May 15, 2017, 3199 children with severe anaemia were enrolled into the TRACT trial. 3188 children were considered in our secondary analysis. The median age was 37 months (IQR 18–64). Whole blood was the first pack provided for 1632 (41%) of 3992 transfusions. Haemoglobin recovery at 8 h was significantly lower in those who received packed cells or settled cells than those who received whole blood, with a mean of 1·4 g/dL (95% CI –1·6 to –1·1) in children who received 30 mL/kg and –1·3 g/dL (–1·5 to –1·0) in those who received 20 mL/kg packed cells versus whole blood, and –1·5 g/dL (–1·7 to –1·3) in those who received 30 mL/kg and –1·0 g/dL (–1·2 to –0·9) in those who received 20 mL/kg settled cells versus whole blood (overall p<0·0001). Compared to whole blood, children who received blood as packed or settled cells in their first transfusion had higher odds of receiving a second transfusion (odds ratio 2·32 [95% CI 1·30 to 4·12] for packed cells and 2·97 [2·18 to 4·05] for settled cells; p<0·001) and longer hospital stays (hazard ratio 0·94 [95% CI 0·81 to 1·10] for packed cells and 0·86 [0·79 to 0·94] for settled cells; p=0·0024). There was no association between the type of blood supplied for the first transfusion and mortality at 28 days or 180 days, or readmission to hospital for any cause. 823 (26%) of 3188 children presented with severe tachycardia and 2077 (65%) with tachypnoea, but these complications resolved over time. No child developed features of confirmed cardiopulmonary overload. Our study suggests that the use of packed or settled cells rather than whole blood leads to additional transfusions, increasing the use of a scarce resource in most of sub-Saharan Africa. These findings have substantial cost implications for blood transfusion and health services. Nevertheless, a clinical trial comparing whole blood transfusion with red cell concentrates might be needed to inform policy makers." @default.
- W4288049407 created "2022-07-27" @default.
- W4288049407 creator A5000445059 @default.
- W4288049407 creator A5001331694 @default.
- W4288049407 creator A5017538208 @default.
- W4288049407 creator A5028638805 @default.
- W4288049407 creator A5029100500 @default.
- W4288049407 creator A5029285301 @default.
- W4288049407 creator A5030902925 @default.
- W4288049407 creator A5033067554 @default.
- W4288049407 creator A5042729842 @default.
- W4288049407 creator A5047881539 @default.
- W4288049407 creator A5065212974 @default.
- W4288049407 creator A5066836044 @default.
- W4288049407 creator A5071689508 @default.
- W4288049407 creator A5073382005 @default.
- W4288049407 creator A5075569206 @default.
- W4288049407 date "2022-03-01" @default.
- W4288049407 modified "2023-10-18" @default.
- W4288049407 title "Whole blood versus red cell concentrates for children with severe anaemia: a secondary analysis of the Transfusion and Treatment of African Children (TRACT) trial" @default.
- W4288049407 cites W1531070701 @default.
- W4288049407 cites W2038981426 @default.
- W4288049407 cites W2085946073 @default.
- W4288049407 cites W2146676860 @default.
- W4288049407 cites W2147825190 @default.
- W4288049407 cites W2149860264 @default.
- W4288049407 cites W2163898127 @default.
- W4288049407 cites W2168580006 @default.
- W4288049407 cites W2172471307 @default.
- W4288049407 cites W2214510465 @default.
- W4288049407 cites W2768847752 @default.
- W4288049407 cites W2889386261 @default.
- W4288049407 cites W2895389643 @default.
- W4288049407 cites W2897732819 @default.
- W4288049407 cites W2921599579 @default.
- W4288049407 cites W2964821070 @default.
- W4288049407 cites W2965425475 @default.
- W4288049407 cites W2968708897 @default.
- W4288049407 cites W3156653215 @default.
- W4288049407 cites W3185364064 @default.
- W4288049407 cites W4210796093 @default.
- W4288049407 cites W88119246 @default.
- W4288049407 doi "https://doi.org/10.1016/s2214-109x(21)00565-9" @default.
- W4288049407 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35180419" @default.
- W4288049407 hasPublicationYear "2022" @default.
- W4288049407 type Work @default.
- W4288049407 citedByCount "4" @default.
- W4288049407 countsByYear W42880494072022 @default.
- W4288049407 countsByYear W42880494072023 @default.
- W4288049407 crossrefType "journal-article" @default.
- W4288049407 hasAuthorship W4288049407A5000445059 @default.
- W4288049407 hasAuthorship W4288049407A5001331694 @default.
- W4288049407 hasAuthorship W4288049407A5017538208 @default.
- W4288049407 hasAuthorship W4288049407A5028638805 @default.
- W4288049407 hasAuthorship W4288049407A5029100500 @default.
- W4288049407 hasAuthorship W4288049407A5029285301 @default.
- W4288049407 hasAuthorship W4288049407A5030902925 @default.
- W4288049407 hasAuthorship W4288049407A5033067554 @default.
- W4288049407 hasAuthorship W4288049407A5042729842 @default.
- W4288049407 hasAuthorship W4288049407A5047881539 @default.
- W4288049407 hasAuthorship W4288049407A5065212974 @default.
- W4288049407 hasAuthorship W4288049407A5066836044 @default.
- W4288049407 hasAuthorship W4288049407A5071689508 @default.
- W4288049407 hasAuthorship W4288049407A5073382005 @default.
- W4288049407 hasAuthorship W4288049407A5075569206 @default.
- W4288049407 hasBestOaLocation W42880494071 @default.
- W4288049407 hasConcept C177713679 @default.
- W4288049407 hasConcept C187212893 @default.
- W4288049407 hasConcept C203014093 @default.
- W4288049407 hasConcept C2776557347 @default.
- W4288049407 hasConcept C2780014101 @default.
- W4288049407 hasConcept C2911063046 @default.
- W4288049407 hasConcept C71924100 @default.
- W4288049407 hasConceptScore W4288049407C177713679 @default.
- W4288049407 hasConceptScore W4288049407C187212893 @default.
- W4288049407 hasConceptScore W4288049407C203014093 @default.
- W4288049407 hasConceptScore W4288049407C2776557347 @default.
- W4288049407 hasConceptScore W4288049407C2780014101 @default.
- W4288049407 hasConceptScore W4288049407C2911063046 @default.
- W4288049407 hasConceptScore W4288049407C71924100 @default.
- W4288049407 hasIssue "3" @default.
- W4288049407 hasLocation W42880494071 @default.
- W4288049407 hasLocation W428804940710 @default.
- W4288049407 hasLocation W428804940711 @default.
- W4288049407 hasLocation W428804940712 @default.
- W4288049407 hasLocation W42880494072 @default.
- W4288049407 hasLocation W42880494073 @default.
- W4288049407 hasLocation W42880494074 @default.
- W4288049407 hasLocation W42880494075 @default.
- W4288049407 hasLocation W42880494076 @default.
- W4288049407 hasLocation W42880494077 @default.
- W4288049407 hasLocation W42880494078 @default.
- W4288049407 hasLocation W42880494079 @default.
- W4288049407 hasOpenAccess W4288049407 @default.
- W4288049407 hasPrimaryLocation W42880494071 @default.
- W4288049407 hasRelatedWork W1965461705 @default.
- W4288049407 hasRelatedWork W1971868458 @default.
- W4288049407 hasRelatedWork W1974357119 @default.